Wikidata

(Q44288471)

English

Cancer and Leukemia Group B 90206: A randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinoma

scientific article published in April 2004

In more languages

Statements

title
Cancer and Leukemia Group B 90206: A randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinoma (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15102658
retrieved
1 December 2017
author name string
Brian I Rini
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15102658
retrieved
1 December 2017
Susan Halabi
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15102658
retrieved
1 December 2017
John Taylor
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15102658
retrieved
1 December 2017
Eric J Small
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15102658
retrieved
1 December 2017
Richard L Schilsky
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15102658
retrieved
1 December 2017
publication date
1 April 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
15102658
retrieved
1 December 2017
page(s)
2584-2586
1 reference
stated in
Europe PubMed Central
PubMed ID
15102658
retrieved
1 December 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44288471&oldid=2109170257"